Symptoms from treatment with sunitinib or sorafenib: a multicenter explorative cohort study to explore the influence of patient-reported outcomes on therapy decisions

Targeted therapies in the treatment of GIST: Adverse events and maximising the benefits of sunitinib through proactive therapy management

(2010) Pascal Wolter et al.   ACTA ONCOLOGICA

What do symptom scores mean: Observations on discrepancies when defining symptoms using words and numbers

(2010) Ashlinder Gill et al.   European Journal of Oncology Nursing

The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study

(2010) Lidwine B. Mokkink et al.   QUALITY OF LIFE RESEARCH

Pharmacological management of gastrointestinal stromal tumours: an update on the role of sunitinib

(2009) J.-Y. Blay   ANNALS OF ONCOLOGY

Relationship between exposure to sunitinib and efficacy and tolerability endpoints in patients with cancer: results of a pharmacokinetic/pharmacodynamic meta-analysis

(2009) Brett E. Houk et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Tolerability of first-line therapy for metastatic renal cell carcinoma

(2009) Camillo Porta et al.   CANCER TREATMENT REVIEWS

Quality of life in patients with metastatic renal cell carcinoma: The importance of patient-reported outcomes

(2009) David Cella   CANCER TREATMENT REVIEWS

A Single Set of Numerical Cutpoints to Define Moderate and Severe Symptoms for the Edmonton Symptom Assessment System

(2009) Debbie Selby et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT

Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer

(2008) A A M van der Veldt et al.   BRITISH JOURNAL OF CANCER

Decision Making in Oncology: A Review of Patient Decision Aids to Support Patient Participation

(2008) D. Stacey et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Exploring the role of novel agents in the treatment of renal cell carcinoma

(2008) Fernando Cotait Maluf et al.   CANCER TREATMENT REVIEWS

Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review

(2008) Kiran Gupta et al.   CANCER TREATMENT REVIEWS

Prospective Comparison of Sorafenib and Sunitinib for Second-Line Treatment of Cytokine-Refractory Kidney Cancer Patients

(2008) Edwin Herrmann et al.   ONCOLOGY

Toxicities Associated with the Administration of Sorafenib, Sunitinib, and Temsirolimus and Their Management in Patients with Metastatic Renal Cell Carcinoma

(2007) Naeem Bhojani et al.   EUROPEAN UROLOGY